Boudreaux
- Additives
- Glycine
“Pharmacy — Each pharmacy ships to different states, and may contain additional additives. Boudreaux / Rush / Hallandale / Greenwich / Align / VialsRx. Additive: Glycine”
Source: mondae.com · Verified 2026-08-09
Mondae Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 9.1/10
Best for: knowing which pharmacy fills the vial — it names Boudreaux
9.1
★★★★★4.6/5
Mondae's strongest column is the clinical side — which molecules it will prescribe, and how it handles dosing.
$115/mo
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
See plans →See plans at Mondae →
Compare top-rated alternatives ↓No insurance needed · Vetted by our editors
One rate holds across every dose, and the one-month and three-month plans cost the same: billed monthly, compounded semaglutide is $115 and compounded tirzepatide $145. Which of six named pharmacies fills your prescription is your choice, an unusual arrangement. Mondae LLC also sells injections of glutathione, NAD+ and sermorelin.
By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
GLP-1 from $115/moPrice shown up frontFlat across dosesIncludes medication + consultAll 50 statesPharmacy namedNo FDA letter on record
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Vetted alternatives to Mondae
★★★★☆4/5
Editorial score · methodology
$119/mo
CompoundedSemaglutideTirzepatideGlutathioneNAD+LegitScript Verified
Get StartedRead full Oak review →★★★☆☆3.3/5
Editorial score · methodology
$249/mo
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript VerifiedFDA Warning
Get StartedRead full Direct Meds review →★★★★☆4.4/5
Editorial score · methodology
$99/mo
CompoundedSemaglutideTirzepatideOrforglipron
Get StartedRead full Found review →Mondae at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $115/mo (Same $115 whether the 1-month or 3-month plan is selected; a struck-through $600 is shown as an anchor price.)
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How Mondae scores
Six columns, each one computed from something Mondae has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where it publishes nothing, that absence is what gets scored. Every seller in the register goes through the same six columns.
Value25%
9.4/10$145/month is 46% below the register median of $267 for compounded tirzepatide.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10On the seller's own pages, a price is published before the questionnaire starts.
Trust & Safety15%
9.0/10names its dispensing pharmacy; shows a price before asking for health information; publishes its state list. Our verification confidence is medium.
Accessibility10%
10.0/10Publishes coverage in 50 of 50 states.
Support10%
7.0/10The price covers medication, consult, shipping.
6weighted dimensions
560sellers in the register
Everychecked against the seller's own site
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%
A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →
What we checked on Mondae
Last checked August 2026- Re-read the price on file across 2 dose or plan tiers
- Checked state coverage: all 50
- Established what the monthly figure covers, and what it leaves out
- Confirmed which compounding pharmacy fills the order, and its accreditation
- Searched our FDA enforcement register for this operator
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below. Editorial confidence in this data: medium.
What signing up with Mondae involves
Assembled from this seller’s entry in the register — the price record, the state list, the dispensing pharmacy where one is named, and what the monthly figure covers. It describes what a reader can expect to meet on the way to a prescription, and what is missing from the seller’s own disclosures. It is not a clinical judgment and not a prescribing decision.
- 1Mondae publishes a price on its own site before asking anything about you. You can compare it against this register without starting a questionnaire.
- 2The intake is a written questionnaire. No live video visit or baseline bloodwork is recorded as required.
- 3A prescription is dispensed by Boudreaux, which Mondae names publicly. Most sellers in this register do not.
- 4The monthly price is recorded as covering medication, consult, shipping.
Price shown before you start
- Cheapest standing monthly prices on record: semaglutide $115, tirzepatide $145. Membership fees, first-month rates and insured copays are excluded from those figures.
- Coverage is published for all 50 states.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
GLP-1 medications Mondae offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
Any dose .2mg-2.3mg (price fixed at every dose)Compounded
$115/mo
semaglutide
Same $115 whether the 1-month or 3-month plan is selected; a struck-through $600 is shown as an anchor price.
Any dose 1.5mg-13.5mg (price fixed at every dose)Compounded
$145/mo
tirzepatide
Same $145 on both the 1-month and 3-month plan.
Check the price yourself before you pay
Every figure here was read off Mondae's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
Mondae compounding-pharmacy partners
Each partner below is a 503A or 503B pharmacy that Mondae routes prescriptions through. Each entry is anchored to a verbatim primary-source quote from the provider’s or pharmacy’s own site.
Rush
- Additives
- Glycine
“Pharmacy — Each pharmacy ships to different states, and may contain additional additives. Boudreaux / Rush / Hallandale / Greenwich / Align / VialsRx. Additive: Glycine”
Source: mondae.com · Verified 2026-08-09
Hallandale
- Additives
- Glycine
“Pharmacy — Each pharmacy ships to different states, and may contain additional additives. Boudreaux / Rush / Hallandale / Greenwich / Align / VialsRx. Additive: Glycine”
Source: mondae.com · Verified 2026-08-09
Greenwich
- Additives
- Glycine
“Pharmacy — Each pharmacy ships to different states, and may contain additional additives. Boudreaux / Rush / Hallandale / Greenwich / Align / VialsRx. Additive: Glycine”
Source: mondae.com · Verified 2026-08-09
Align
- Additives
- Glycine
“Pharmacy — Each pharmacy ships to different states, and may contain additional additives. Boudreaux / Rush / Hallandale / Greenwich / Align / VialsRx. Additive: Glycine”
Source: mondae.com · Verified 2026-08-09
VialsRx
- Additives
- Glycine
“Pharmacy — Each pharmacy ships to different states, and may contain additional additives. Boudreaux / Rush / Hallandale / Greenwich / Align / VialsRx. Additive: Glycine”
Source: mondae.com · Verified 2026-08-09
In its favor
- Semaglutide at $115 a month, 39% below the $189 median for the same drug and form across this register
- Tirzepatide at $145 a month, 46% below the $267 median for the same drug and form across this register
- Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
- The monthly figure covers medication, consult, shipping
- Coverage is published for all 50 states
- Names 6 dispensing pharmacies, which most sellers in this register do not do
- No FDA warning letter matched this operator when we searched our enforcement register
Against it
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Mondae charges
Mondae lists $115/month, flat regardless of dose. That sits at the affordable end of what we track. Flat dose pricing matters more than it reads: on a tiered plan the bill grows as the dose does, which means the figure that persuaded you to sign up is not the figure you end up living with.
- Compounded semaglutide — $115/month
- Compounded tirzepatide — $145/month
Across the GLP-1 providers in our register the median standing price is about $169/month, so Mondae is genuinely under the middle rather than merely advertising that it is.
Oak, at about $119/month, is the closest thing we track to a like-for-like alternative.
What Mondae dispenses
Mondae prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. The medication is compounded rather than dispensed as an approved pen. Compounding serves real clinical needs and is entirely lawful; what it is not is reviewed, and the cost difference reflects that.
What we could verify
On the record: it treats patients in all 50 states and it names the pharmacy that fills its prescriptions. We searched the federal warning-letter record for this operator and came back with nothing. Because the medication is compounded, the named pharmacy is the detail that matters most here — it is the license you can actually look up. How we weigh oversight, disclosure and price evidence is set out in our scoring methodology.
Who should look elsewhere
- You want the FDA-approved pen specifically. Nothing here is the approved finished product.
- You need to bill insurance. Like most of this market, this is cash-pay.
It fits if
- the lowest standing monthly cost is what you are solving for
- you want the price to stop moving as your dose climbs
- you need access regardless of where you live
Our read
Mondae competes on price and does it without an obvious sacrifice elsewhere: $115/month, no warning letter on file, and access that is not unusually restricted.
The Bottom Line
Mondae's strongest column is the clinical side — which molecules it will prescribe, and how it handles dosing.
Score: 9.1/10Best for: knowing which pharmacy fills the vial — it names BoudreauxFrom: $115/mo
Before you pay Mondae
Starting at $115/month. Check today's price, then book the free consultation.
Where Mondae is the wrong choice
No seller in this register suits every reader, and saying otherwise would be the easiest way to sell one. On these four counts another entry does better.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Mondae review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Mondae's current pricing
Plans start at $115/month. The free consultation is where you learn whether you qualify, and what it costs today.
Not sold on Mondae?
Vetted alternatives